menu
    • menu

    Company profile for Oncocross

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Oncocross is making innovations in the field of drug development based on artificial intelligence.Oncocross's artificial intelligence platform presents optimal indications for new drugs being developed by pharmaceutical companies or research institutes. In particular, anticancer drugs are screened for which type of cancer is optimal, minimizing the risks associated with drug development. Through this, we will develop treatmen...
    Oncocross is making innovations in the field of drug development based on artificial intelligence.Oncocross's artificial intelligence platform presents optimal indications for new drugs being developed by pharmaceutical companies or research institutes. In particular, anticancer drugs are screened for which type of cancer is optimal, minimizing the risks associated with drug development. Through this, we will develop treatments for incurable diseases such as cancer and rare diseases for which there is currently no treatment, thereby contributing to the health of not only Korea but also all mankind.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Oncocrosskorearepublicofnew Flag
    Country
    Country
    South Korea
    Address
    Address
    11th, 16th floor, Saechang-ro, Mapo-gu, Seoul
    Telephone
    Telephone
    02-867-9967
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.oncocross.com/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Oncocross, JW Pharma: AI-Driven Anticancer, Regenerative Drug Development
    Oncocross, JW Pharma: AI-Driven Anticancer, Regenerative Drug Development

    27 May 2024

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20240528528566/en

    BUSINESSWIRE
    27 May 2024
    Share Share
    Oncocross expands collab with JW for AI-based oncology drug discovery in Korea
    Oncocross expands collab with JW for AI-based oncology drug discovery in Korea

    27 May 2024

    // BIOSPECTRUM ASIA

    https://www.biospectrumasia.com/news/34/24309/oncocross-expands-collaboration-with-jw-pharma-for-ai-based-oncology-drug-discovery-in-korea.html

    BIOSPECTRUM ASIA
    27 May 2024
    Share Share
    Oncocross completes Phase I sarcopenia trial in Australia
    Oncocross completes Phase I sarcopenia trial in Australia

    11 May 2023

    // CLINICAL TRIALS ARENA

    https://www.clinicaltrialsarena.com/news/oncocross-phase-i-sarcopenia-trial/

    CLINICAL TRIALS ARENA
    11 May 2023
    Share Share
    Oncocross Completes Phase I Global Clinical Trial of OC514, for Sarcopenia
    Oncocross Completes Phase I Global Clinical Trial of OC514, for Sarcopenia

    10 May 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230510005425/en

    BUSINESSWIRE
    10 May 2023
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search